Data storage provider Western Digital must pay SPEX Technologies more than $237 million in interest on top of $316 million in ...

This Agreement resolves the patent litigation brought by Catalyst and its licensor SERB S.A in response to Teva’s Abbreviated New Drug Application (ANDA) seeking approval to market a generic ...

Apple has responded to a lawsuit over its iPhone 15 camera technology, asking a court to strike claims based on a pre-trial ...

Back before the holidays, we checked in with a handful of Big Law litigation leaders to hear what they’re looking out for in ...

Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company ...

IBM and video game maker Take-Two Interactive told a Delaware federal court on Monday that IBM is dismissing its lawsuit that ...

Intra-Cellular Therapies (ITCI) announced that it has entered into a settlement agreement with Sandoz (SDZNY) resolving patent litigation ...

Shares of Catalyst Pharmaceuticals CPRX gained 16.7% on Wednesday after the company, along with its licensor, SERB, announced ...

Catalyst Pharmaceuticals settles patent litigation with Teva, delaying generic Firdapse launch until 2035. Legal actions against other defendants remain ongoing.

Intra-Cellular Therapies, Inc. announced a settlement with Sandoz Inc. regarding patent litigation involving their product CAPLYTA® (lumateperone). This litigation arose from Sandoz's attempt to ...

Kathryn Bi joined Patterson Belknap Webb & Tyler as a partner in its litigation department in New York, the firm announced ...

Morgan Lewis has continued its Unified Patent Court-related hiring push with the appointment of Alexander Ritter as a partner ...